ReCode Therapeutics Competitors and Similar CompaniesClear all

ReCode Therapeutics's competitors and similar companies include BillionToOne and Verona Pharma.

	ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.	BillionToOne BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options.	Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Founding Date	Founding Date 2015	Founding Date 2016	Founding Date N/A
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare bioengineering biotech genetics nanotech pharma	Tags Healthcare biotech genetics medical devices medical diagnostics platform	Tags Healthcare biotech pharma
Locations	Locations Menlo Park, US HQ	Locations Menlo Park, US HQ	Locations London, GB HQ Cardiff, GB Raleigh, US
Employees	Employees 1062% decrease	Employees 620	Employees 79
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $305.1m (FY, 2025)	Revenue (est.) $42.3m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods $96.7m (FY, 2025)	Cost of goods $1.4m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit $208.5m (FY, 2025)	Gross profit $40.9m (FY, 2024)
Net income	Net income N/A	Net income $7.5m (FY, 2025)	Net income ($173.2m) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 82m	Total funding raised $ 87.5m	Total funding raised $ 11.5m